Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression

被引:98
作者
Cacev, Tamara [1 ]
Radosevic, Senka [2 ]
Krizanac, Simun [3 ]
Kapitanovic, Sanja [1 ]
机构
[1] Rudjer Boskovic Inst, Div Mol Med, Zagreb 10000, Croatia
[2] PLIVA DD Res & Dev, Zagreb 10000, Croatia
[3] Univ Zagreb, Clin Hosp Dubrava, Zagreb 10000, Croatia
关键词
D O I
10.1093/carcin/bgn164
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytokines produced in the tumour microenvironment have an important role in cancer pathogenesis. Altered cytokine expression may result in increased susceptibility to and/or poor prognosis in certain cancers. Therefore, the aim of this study was to investigate the influence of interleukin (IL)-8 and IL-10 on sporadic colon cancer development and progression. In our study, a statistically significant increase in IL-8 messenger RNA (mRNA) expression and decrease in IL-10 mRNA expression in tumour tissue compared with normal mucous tissue was observed (P = 0.003; P = 1.3 x 10(-9)). No association was found between IL-8 2251 A/T genotypes and IL-8 mRNA expression in tumour and corresponding normal mucous tissue, as well as susceptibility to sporadic colon cancer. Positive immunohistochemical IL-8 staining was more frequent in moderately and poorly differentiated tumours compared with well- differentiated tumours (P = 0.024). Finally, IL-8 significantly stimulated invasion of HT-29 cells in vitro (P = 0.000172). Significant association of IL-10 -1082 A/G, -819 T/C and -592 A/C genotypes and IL-10 mRNA expression in tumour tissue was observed (P = 0.022; P = 0.013; P = 0.02). Significant association of 2819 T/C and 2592 A/C genotypes and IL-10 mRNA expression in corresponding normal mucous tissue was observed (P = 0.01; P = 0.04) as well. IL-10 single-nucleotide polymorphism (SNP) promoter genotypes associated with low IL-10 mRNA expression (2819 TT; 2592 AA) were also associated with increased risk of sporadic colon cancer compared with high-expression genotypes [odds ratio, 5.53; 95% confidence interval (CI), 1.53-20.1; odds ratio, 4.07; 95% CI, 1.28-12.96]. Positive IL-10 immunohistochemical reaction was more frequent in well- differentiated and moderately differentiated tumours compared with poorly differentiated tumours (P = 0.036). In Dukes' C tumours, positive IL-10 immunohistochemical reaction was less frequent compared with Dukes' A and B tumours (P = 0.023). Taken together, our results point to possible tumour promoting role of IL-8 and potential protective role of IL-10 in sporadic colon cancer.
引用
收藏
页码:1572 / 1580
页数:9
相关论文
共 51 条
[1]   IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response [J].
Adris, SK ;
Klein, S ;
Jasnis, MA ;
Chuluyan, E ;
Ledda, MF ;
Bravo, AI ;
Carbone, C ;
Chernajovsky, Y ;
Podhajcer, OL .
GENE THERAPY, 1999, 6 (10) :1705-1712
[2]   Interleukin-10 therapy - Review of a new approach [J].
Asadullah, K ;
Sterry, W ;
Volk, HD .
PHARMACOLOGICAL REVIEWS, 2003, 55 (02) :241-269
[3]   In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease [J].
Autschbach, F ;
Braunstein, J ;
Helmke, B ;
Zuna, I ;
Schürmann, G ;
Niemir, ZI ;
Wallich, R ;
Otto, HF ;
Meuer, SC .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01) :121-130
[4]   Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival [J].
Bellone, G ;
Smirne, C ;
Mauri, FA ;
Tonel, E ;
Carbone, A ;
Buffolino, A ;
Dughera, L ;
Robecchi, A ;
Pirisi, M ;
Emanuelli, G .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (06) :684-698
[5]   NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer [J].
Cacev, T ;
Radosevic, S ;
Spaventi, R ;
Pavelic, K ;
Kapitanovic, S .
GUT, 2005, 54 (08) :1129-1135
[6]  
Chung YC, 2003, HEPATO-GASTROENTEROL, V50, P1910
[7]  
Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO
[8]  
2-Y
[9]  
De Vita F, 1999, CANCER, V86, P1936, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.3.CO
[10]  
2-0